← Back to Clinical Trials
Recruiting EARLY_Phase 1 NCT03708627
Bimatoprost as a Treatment for Graves' Orbitopathy
Trial Parameters
Condition Graves Ophthalmopathy
Sponsor Johns Hopkins University
Study Type INTERVENTIONAL
Phase EARLY_Phase 1
Enrollment 3
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2017-11-01
Completion 2029-07-01
Interventions
Bimatoprost Ophthalmic
Brief Summary
Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease
Eligibility Criteria
Inclusion Criteria: Graves' Ophthalmopathy with Exophthalmos/Proptosis - Exclusion Criteria: Active Graves Disease, Currently pregnant, Taking Steroids \-
Related Trials
NCT06112340
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye D
View Trial →
NCT03708627
Bimatoprost as a Treatment for Graves' Orbitopathy
View Trial →
NCT06275373
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
View Trial →